This is likely our last chance to close the gap, and their last chance to cover those shorts.
What will the price do when trial results are great? What if that is rapidly filtered by FDA approval for a whole other indication, which means more insurance reimbursing?
What if BARDA decides to stockpile a large quantity? They are funding these expensive trials for a reason after all.
I would hate to be short, staring at a screen of red, needing to unload 18m shares when daily volume is 1.5m....
good luck everyone
This is likely our last chance to close the gap, and their last...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.49 |
Change
-0.120(4.60%) |
Mkt cap ! $1.719B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.74 | $2.49 | $5.988M | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 38045 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 27863 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |